share_log

Pharmaxis to Be Renamed Syntara and Will Primarily Focus on Clinical Development

Pharmaxis to Be Renamed Syntara and Will Primarily Focus on Clinical Development

Pharmaxis 將更名爲 Syntara,將主要專注於臨床開發
道瓊斯 ·  2023/10/02 18:43

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論